Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test Panel Confirms Presence of ASBL Enzymes

By HospiMedica staff writers
Posted on 09 May 2002
A new test panel enables microbiology laboratories to definitively confirm the presence of extended-spectrum beta-lactamase (ESBL) enzymes detected by screening methods.

Confirmed detection of ESBL can indicate the presence of bacterial strains that produce the enzymes. More...
These strains include E coli, K pneumoniae, and K oxytoca, each of which may be clinically resistant to therapy with penicillins, cephalosporins, and astreonam. Clinical laboratory guidelines recommend both screening and confirmation testing for potential ESBL-producing bacteria. The new panel, called MicroScan, is designed to help laboratories comply.

The new panel also provides doctors with susceptibility results for imipenem and meropenem, each recommended treatment choices for confirmed ESBL isolates and for non-ESBL isolates. Researchers may also find the panel useful for studying emerging resistance, since it provides susceptibility results for cefotetan, cefoxitin, and piperacillin.

"Bacterial resistance to antibodies is a concern,” said Bob Brightfelt, president, global research and development, Dade Behring, Inc. (Deerfield, IL, USA). "This new panel is a means of reaching more accurate diagnoses and can lead to identifying effective treatments to manage a number of potentially serious infections that may pose the challenge of drug resistance.”




Related Links:
Dade Behring

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.